Cybin (HELP) Goodwill & Intangibles (2021 - 2026)
Cybin (HELP) posted quarterly Goodwill & Intangibles of $66.4 million for Q1 2026, up 3.07% year-on-year from $64.5 million in Q1 2025, and down 0.87% on a QoQ basis from $67.0 million in Q4 2025.
Cybin (HELP) Goodwill & Intangibles (2021 - 2026) Analysis & Trends
Cybin (HELP) has reported Goodwill & Intangibles for 6 consecutive years, with $66.4 million the latest figure, recorded in Q1 2026.
- Quarterly Goodwill & Intangibles rose 3.07% year-over-year to $66.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $66.4 million (up 3.07% YoY) and the FY2026 annual result came in at $66.4 million, changed 0.14% from the prior year.
- Goodwill & Intangibles eased to $66.4 million in Q1 2026 per HELP's latest filing, from $67.0 million in the prior quarter.
- Over the last five years, Goodwill & Intangibles for HELP reached as high as $67.1 million in Q2 2025 and fell as low as $22.2 million in Q4 2022.
- A 5-year average of $53.0 million and a median of $61.2 million in 2024 frame the typical range for Goodwill & Intangibles.
- Annual changes were most pronounced in 2023 — Goodwill & Intangibles declined 1.76% — and 2024, when it soared 168.04%.
- Year by year, Goodwill & Intangibles stood at $22.2 million in 2022, then jumped by 166.31% to $59.0 million in 2023, then climbed by 3.91% to $61.3 million in 2024, then climbed by 9.3% to $67.0 million in 2025, then decreased by 0.87% to $66.4 million in 2026.
- According to Business Quant data, Goodwill & Intangibles over the past three periods registered $66.4 million, $67.0 million, and $66.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Cybin | 28.04 Mn | 28.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 66.45 Mn |
| Dec 31, 2025 | 67.03 Mn |
| Sep 30, 2025 | 66.54 Mn |
| Jun 30, 2025 | 67.08 Mn |
| Mar 31, 2025 | 64.47 Mn |
| Dec 31, 2024 | 61.33 Mn |
| Sep 30, 2024 | 61.08 Mn |
| Jun 30, 2024 | 61.01 Mn |
| Mar 31, 2024 | 61.55 Mn |
| Dec 31, 2023 | 59.02 Mn |
| Sep 30, 2023 | 22.79 Mn |
| Jun 30, 2023 | 37.86 Mn |
| Dec 31, 2022 | 22.16 Mn |
| Sep 30, 2022 | 23.20 Mn |
| Dec 31, 2021 | 20.02 Mn |
| Sep 30, 2021 | 20.03 Mn |
| Jun 30, 2021 | 19.90 Mn |
| Mar 31, 2021 | 18.54 Mn |